Issues New Compulsory Licenses; Signs Harmful Trade Agreement with the EU [Luz Marina Umbasia and Peter Maybarduk, Link to PDF] In July, Ecuador issued four compulsory licenses for medicines targeting cancer and arthritis treatment and immunological reception to kidney transplant.[1] These licenses authorize cost-cutting generic competition with patented medicines, in exchange for royalty payments to [...]
↧